Pages that link to "Q37683586"

The following pages link to Alkylating agent resistance: in vitro studies with human cell lines (Q37683586):

Displaying 42 items.

• Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites (Q32117273) (← links)
• Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. (Q33556647) (← links)
• Overview of autologous stem cell transplantation. (Q34038567) (← links)
• Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review (Q34298244) (← links)
• Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells (Q34360262) (← links)
• Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer (Q34886445) (← links)
• Innovations in design and delivery of chemotherapy for brain tumors (Q35104257) (← links)
• Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes (Q36080744) (← links)
• Metabolism and transport of oxazaphosphorines and the clinical implications (Q36360811) (← links)
• Antineoplastic Drug Resistance in Brain Tumors (Q36530439) (← links)
• Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA (Q36688531) (← links)
• Mechanisms of cellular resistance to cisplatin (Q39519222) (← links)
• Resistance to cisplatin and analogues: mechanisms and potential clinical implications (Q39525356) (← links)
• The role of high-dose therapy and autologous bone marrow reinfusion in the treatment of malignant lymphomas (Q39533043) (← links)
• BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models (Q39985326) (← links)
• A pilot trial of tandem autologous peripheral blood progenitor cell transplantation following high-dose thiotepa and carboplatin in children with poor-risk central nervous system tumors (Q40518066) (← links)
• High dose chemotherapy with autologous stem cell support for the treatment of metastatic breast cancer. (Q40657351) (← links)
• Transfer of human genes conferring resistance to methylating mutagens, but not to UV irradiation and cross-linking agents, into Chinese hamster ovary cells (Q40686334) (← links)
• Clinical Trial: Hematopoietic Progenitor Cell Transplantation in Breast Cancer: Current Status and Future Directions (Q40865994) (← links)
• Nitrogen mustard up-regulates Bcl-2 and GSH and increases NTP and PCr in HT-29 colon cancer cells (Q41028120) (← links)
• Dose-intensified treatment of breast cancer: current results (Q41126585) (← links)
• Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment (Q41149667) (← links)
• Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines (Q41256624) (← links)
• Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo (Q41393623) (← links)
• High-dose chemotherapy with autologous stem cell support for the treatment of advanced ovarian cancer--initial experience in Uppsala and Turku (Q41489742) (← links)
• In vivo modulation of several anticancer agents by beta-carotene (Q41501304) (← links)
• Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies (Q41584912) (← links)
• Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells. (Q41732983) (← links)
• Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro. (Q41751710) (← links)
• Damage-recognition proteins as a potential indicator of DNA-damage-mediated sensitivity or resistance of human cells to ultraviolet radiation (Q41791031) (← links)
• Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment (Q42079536) (← links)
• Development of alkylating agent-resistant human tumor cell lines (Q44869826) (← links)
• ?-Carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells (Q47571076) (← links)
• Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies (Q48223323) (← links)
• Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. (Q54252495) (← links)
• Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II) (Q54303586) (← links)
• Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol. (Q54363304) (← links)
• Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas. (Q55481269) (← links)
• Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin (Q64389629) (← links)
• High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Breast Cancer (Q71784766) (← links)
• A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies (Q73616916) (← links)
• Why Great Mitotic Inhibitors Make Poor Cancer Drugs (Q96343724) (← links)